EVOLVA HOLDING SA |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.996 CHF | +10.42% |
|
+1.63% | +38.33% |
| Apr. 15 | Evolva Shareholders Pass Resolutions to Revoke Liquidation, Delisting | MT |
| Mar. 26 | Evolva Secures Temporary Exemption from Listing Rules Amid Liquidation | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2022 | 15.54M 17.11M | Sales 2023 | 4.16M 4.58M | Capitalization | 4.9M 5.4M |
|---|---|---|---|---|---|
| Net income 2022 | -43M -47.34M | Net income 2023 | -101M -111M | EV / Sales 2022 | 6.5 x |
| Net Debt 2022 | 9.91M 10.91M | Net cash position 2023 | 5.84M 6.43M | EV / Sales 2023 | -0.23 x |
| P/E ratio 2022 |
-2.02
x | P/E ratio 2023 |
-0.05
x | Employees | 49 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 64.93% |
More Fundamentals
* Assessed data
More news
Latest transcript on Evolva Holding SA
More recommendations
More press releases
More news
| 1 day | +10.42% | ||
| 1 week | +1.63% | ||
| Current month | -1.39% | ||
| 1 month | -4.23% | ||
| 3 months | +61.69% | ||
| 6 months | -70.18% | ||
| Current year | +38.33% |
1 week
0.90
1.00
1 month
0.901.07
Current year
0.621.09
1 year
0.6217.00
3 years
0.6248.50
5 years
0.6293.50
10 years
0.62465.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 22-02-07 | |
Gerhard Lobmaier
COO | Chief Operating Officer | 55 | 20-12-31 |
Astrid Schäfer
CTO | Chief Tech/Sci/R&D Officer | 51 | 17-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 60 | 20-04-14 | |
Beat In-Albon
BRD | Director/Board Member | 72 | 20-04-14 |
Andreas Pfluger
BRD | Director/Board Member | 64 | 22-03-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-08 | 0.996 | +10.42% | 1 402 |
| 24-05-07 | 0.902 | -0.22% | 2,147 |
| 24-05-06 | 0.904 | 0.00% | 4,405 |
| 24-05-03 | 0.904 | -7.76% | 4,130 |
| 24-05-02 | 0.98 | -2.97% | 1,469 |
Delayed Quote Swiss Exchange, May 08, 2024 at 07:33 am EDT
More quotes
Evolva Holding SA (Evolva) is a Switzerland-based biotechnology company reseaching, developing and commerzializing nature-based ingrendients. The activity of the Company is divided into two segments: technololgy platforms - combines biology with technology to produce nature-based ingredients; technology servises- provides tailored services to clients across industries. The Company is focused on developing and increase the yield and efficiency of the production of various ingredients.
Calendar
2024-08-21
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +38.33% | 7.17M | |
| +21.74% | 46.4B | |
| -0.97% | 41.75B | |
| +48.20% | 41.37B | |
| -3.52% | 29.71B | |
| +11.12% | 26.01B | |
| -19.37% | 19.52B | |
| +31.18% | 12.43B | |
| +0.39% | 12.18B | |
| -0.04% | 12.13B |
- Stock Market
- Equities
- EVE Stock